leukocyte Search Results


98
Miltenyi Biotec cd11b c fitc
Cd11b C Fitc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/leukocyte/CD11b%2Fc+Antibody%2C+anti-rat%2C+REAfinity/pmc06896275-34-35-41
Average 98 stars, based on 1 article reviews
cd11b c fitc - by Bioz Stars, 2026-09
98/100 stars
  Buy from Supplier

94
Athens Research human neutrophil elastase
Human Neutrophil Elastase, supplied by Athens Research, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/leukocyte/Elastase/10__1074_slash_jbc__m400261200-112-13-27
Average 94 stars, based on 1 article reviews
human neutrophil elastase - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

94
Kingfisher Biotech recombinant bovine il 1β
Recombinant Bovine Il 1β, supplied by Kingfisher Biotech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/leukocyte/Bovine+IL-1+beta+Recombinant+Protein/pmc12580949-76-41-44
Average 94 stars, based on 1 article reviews
recombinant bovine il 1β - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

96
Proteintech cd45
Cd45, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/leukocyte/CD45+Antibody/pmc12973573-94-25-27
Average 96 stars, based on 1 article reviews
cd45 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

90
Proteintech anti cd48
Anti Cd48, supplied by Proteintech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/leukocyte/CD48+Antibody/pmc12956714-80-45-47
Average 90 stars, based on 1 article reviews
anti cd48 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

93
Proteintech anti cd62l
Anti Cd62l, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/leukocyte/CD62L+Antibody/pmc11729565-260-20-21
Average 93 stars, based on 1 article reviews
anti cd62l - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

96
Proteintech cd9
LTH-sEV promotes LSEC capillarization in HFD mice and aggravates the progression of MASLD. ( A ) NTA analysis of LTH-sEV; ( B ) TEM images of LTH-sEV, scale bar = 100 nm; ( C ) Western blot analysis of <t>CD9,</t> CD63, Alix, TSG101, and calnexin protein expression in hepatocyte (HepG2) and LTH-sEV; ( D ) Schematic diagram of LTH-sEV injection into mice on HFD and NCD diet; ( E ) In vivo imaging detection of DiR-labeled LTH-sEV in mice; ( F ) SEM images and porosity of hepatic sinusoidal in NCD-fed mice treated with PBS, LTH-sEV, HFD-fed mice treated with PBS, LTH-sEV, n = 6, scale bar = 500 nm; ( G ) Immunohistochemistry images of CD31, Ang-2 in each group, scale bar = 50 μm, n = 6; ( H ) ELISA analysis of serum Ang-2 in each group, n = 6; ( I ) Western blot analysis of Ang-2 expression in each group, n = 3; ( J ) H&E staining, immunohistochemistry images of α-SMA, Sirius red staining in each group, scale bar = 50 μm, n = 6; ( K ) Serum ALT, AST expression in each group, n = 6; ( L ) qRT-PCR analysis of IL-1β, IL-6, and TNFα expression in each group, n = 6; ( M ) ELISA analysis of IL-1β, IL-6, and TNFα level in mice liver or serum, n = 6. Compared with HFD or NCD group, ∗ P < .05; ∗∗ P < .01; ∗∗∗ P < .001; ns, no significance.
Cd9, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/leukocyte/CD9+Antibody/pmc12945584-292-39-40
Average 96 stars, based on 1 article reviews
cd9 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

94
MedChemExpress s100a8
Effects of estrogen treatment on <t>S100A8</t> expression in endometrium and epithelium morphology. ( a ) S100A8 immunohistochemical staining before and after estrogen treatment (1d/7d); black arrows indicate S100A8-positive immune cells (S100A8-PICs).The blue arrow indicates the release of S100A8 from S100A8-PICs. Scale bar is 100 or 400 μm. ( b ) Rat endometrial hematoxylin–eosin staining before and after estrogen treatment (1d/7d); red arrows show disrupted cell junctions. Scale bar is 100 μm. ( c ) S100A8-PICs number in the endometrium (1/mm 2 ) before and 1 d/7d after estrogen treatment (n = 18, from six rats, the number was counted from three immunohistochemical images of each sample , mean ± SEM). ( d ) S100A8 expression in the epithelium before and 1 d/7d after estrogen treatment (n = 18, from six rats, the expression level was measured from three immunohistochemical images of each sample, mean ± SEM). * Results with P values < 0.05 were considered significant. ** Results with P values < 0.01 were considered very significant.
S100a8, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/leukocyte/S100A8%2C+Rat/pmc12219834-197-16-22
Average 94 stars, based on 1 article reviews
s100a8 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

93
Beijing Solarbio Science human peripheral blood leukocyte isolation kit
Effects of estrogen treatment on <t>S100A8</t> expression in endometrium and epithelium morphology. ( a ) S100A8 immunohistochemical staining before and after estrogen treatment (1d/7d); black arrows indicate S100A8-positive immune cells (S100A8-PICs).The blue arrow indicates the release of S100A8 from S100A8-PICs. Scale bar is 100 or 400 μm. ( b ) Rat endometrial hematoxylin–eosin staining before and after estrogen treatment (1d/7d); red arrows show disrupted cell junctions. Scale bar is 100 μm. ( c ) S100A8-PICs number in the endometrium (1/mm 2 ) before and 1 d/7d after estrogen treatment (n = 18, from six rats, the number was counted from three immunohistochemical images of each sample , mean ± SEM). ( d ) S100A8 expression in the epithelium before and 1 d/7d after estrogen treatment (n = 18, from six rats, the expression level was measured from three immunohistochemical images of each sample, mean ± SEM). * Results with P values < 0.05 were considered significant. ** Results with P values < 0.01 were considered very significant.
Human Peripheral Blood Leukocyte Isolation Kit, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/leukocyte/Human+Peripheral+Blood+Leukocyte+Isolation+Solution+Kit/pm40169697-90-18-24
Average 93 stars, based on 1 article reviews
human peripheral blood leukocyte isolation kit - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

94
Kingfisher Biotech bovine il 1 beta elisa reagent kit ess0027
Effects of estrogen treatment on <t>S100A8</t> expression in endometrium and epithelium morphology. ( a ) S100A8 immunohistochemical staining before and after estrogen treatment (1d/7d); black arrows indicate S100A8-positive immune cells (S100A8-PICs).The blue arrow indicates the release of S100A8 from S100A8-PICs. Scale bar is 100 or 400 μm. ( b ) Rat endometrial hematoxylin–eosin staining before and after estrogen treatment (1d/7d); red arrows show disrupted cell junctions. Scale bar is 100 μm. ( c ) S100A8-PICs number in the endometrium (1/mm 2 ) before and 1 d/7d after estrogen treatment (n = 18, from six rats, the number was counted from three immunohistochemical images of each sample , mean ± SEM). ( d ) S100A8 expression in the epithelium before and 1 d/7d after estrogen treatment (n = 18, from six rats, the expression level was measured from three immunohistochemical images of each sample, mean ± SEM). * Results with P values < 0.05 were considered significant. ** Results with P values < 0.01 were considered very significant.
Bovine Il 1 Beta Elisa Reagent Kit Ess0027, supplied by Kingfisher Biotech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/leukocyte/Bovine+IL-1+beta+ELISA/pm31732699-59-28-36
Average 94 stars, based on 1 article reviews
bovine il 1 beta elisa reagent kit ess0027 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

94
Kingfisher Biotech guinea pig
Effects of estrogen treatment on <t>S100A8</t> expression in endometrium and epithelium morphology. ( a ) S100A8 immunohistochemical staining before and after estrogen treatment (1d/7d); black arrows indicate S100A8-positive immune cells (S100A8-PICs).The blue arrow indicates the release of S100A8 from S100A8-PICs. Scale bar is 100 or 400 μm. ( b ) Rat endometrial hematoxylin–eosin staining before and after estrogen treatment (1d/7d); red arrows show disrupted cell junctions. Scale bar is 100 μm. ( c ) S100A8-PICs number in the endometrium (1/mm 2 ) before and 1 d/7d after estrogen treatment (n = 18, from six rats, the number was counted from three immunohistochemical images of each sample , mean ± SEM). ( d ) S100A8 expression in the epithelium before and 1 d/7d after estrogen treatment (n = 18, from six rats, the expression level was measured from three immunohistochemical images of each sample, mean ± SEM). * Results with P values < 0.05 were considered significant. ** Results with P values < 0.01 were considered very significant.
Guinea Pig, supplied by Kingfisher Biotech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/leukocyte/Guinea+Pig+IL-1+beta+Recombinant+Protein/us11267884-704-44-46
Average 94 stars, based on 1 article reviews
guinea pig - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

90
Proteintech cd43 antibody
Effects of estrogen treatment on <t>S100A8</t> expression in endometrium and epithelium morphology. ( a ) S100A8 immunohistochemical staining before and after estrogen treatment (1d/7d); black arrows indicate S100A8-positive immune cells (S100A8-PICs).The blue arrow indicates the release of S100A8 from S100A8-PICs. Scale bar is 100 or 400 μm. ( b ) Rat endometrial hematoxylin–eosin staining before and after estrogen treatment (1d/7d); red arrows show disrupted cell junctions. Scale bar is 100 μm. ( c ) S100A8-PICs number in the endometrium (1/mm 2 ) before and 1 d/7d after estrogen treatment (n = 18, from six rats, the number was counted from three immunohistochemical images of each sample , mean ± SEM). ( d ) S100A8 expression in the epithelium before and 1 d/7d after estrogen treatment (n = 18, from six rats, the expression level was measured from three immunohistochemical images of each sample, mean ± SEM). * Results with P values < 0.05 were considered significant. ** Results with P values < 0.01 were considered very significant.
Cd43 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/leukocyte/CD43+Antibody/10__2147_slash_cmar__s278903-85-1-4
Average 90 stars, based on 1 article reviews
cd43 antibody - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


LTH-sEV promotes LSEC capillarization in HFD mice and aggravates the progression of MASLD. ( A ) NTA analysis of LTH-sEV; ( B ) TEM images of LTH-sEV, scale bar = 100 nm; ( C ) Western blot analysis of CD9, CD63, Alix, TSG101, and calnexin protein expression in hepatocyte (HepG2) and LTH-sEV; ( D ) Schematic diagram of LTH-sEV injection into mice on HFD and NCD diet; ( E ) In vivo imaging detection of DiR-labeled LTH-sEV in mice; ( F ) SEM images and porosity of hepatic sinusoidal in NCD-fed mice treated with PBS, LTH-sEV, HFD-fed mice treated with PBS, LTH-sEV, n = 6, scale bar = 500 nm; ( G ) Immunohistochemistry images of CD31, Ang-2 in each group, scale bar = 50 μm, n = 6; ( H ) ELISA analysis of serum Ang-2 in each group, n = 6; ( I ) Western blot analysis of Ang-2 expression in each group, n = 3; ( J ) H&E staining, immunohistochemistry images of α-SMA, Sirius red staining in each group, scale bar = 50 μm, n = 6; ( K ) Serum ALT, AST expression in each group, n = 6; ( L ) qRT-PCR analysis of IL-1β, IL-6, and TNFα expression in each group, n = 6; ( M ) ELISA analysis of IL-1β, IL-6, and TNFα level in mice liver or serum, n = 6. Compared with HFD or NCD group, ∗ P < .05; ∗∗ P < .01; ∗∗∗ P < .001; ns, no significance.

Journal: Cellular and Molecular Gastroenterology and Hepatology

Article Title: OGT-enriched Hepatocyte-derived Extracellular Vesicles Promote Capillarization of Liver Sinusoidal Endothelial Cells in Metabolic Dysfunction-associated Steatotic Liver Disease

doi: 10.1016/j.jcmgh.2025.101721

Figure Lengend Snippet: LTH-sEV promotes LSEC capillarization in HFD mice and aggravates the progression of MASLD. ( A ) NTA analysis of LTH-sEV; ( B ) TEM images of LTH-sEV, scale bar = 100 nm; ( C ) Western blot analysis of CD9, CD63, Alix, TSG101, and calnexin protein expression in hepatocyte (HepG2) and LTH-sEV; ( D ) Schematic diagram of LTH-sEV injection into mice on HFD and NCD diet; ( E ) In vivo imaging detection of DiR-labeled LTH-sEV in mice; ( F ) SEM images and porosity of hepatic sinusoidal in NCD-fed mice treated with PBS, LTH-sEV, HFD-fed mice treated with PBS, LTH-sEV, n = 6, scale bar = 500 nm; ( G ) Immunohistochemistry images of CD31, Ang-2 in each group, scale bar = 50 μm, n = 6; ( H ) ELISA analysis of serum Ang-2 in each group, n = 6; ( I ) Western blot analysis of Ang-2 expression in each group, n = 3; ( J ) H&E staining, immunohistochemistry images of α-SMA, Sirius red staining in each group, scale bar = 50 μm, n = 6; ( K ) Serum ALT, AST expression in each group, n = 6; ( L ) qRT-PCR analysis of IL-1β, IL-6, and TNFα expression in each group, n = 6; ( M ) ELISA analysis of IL-1β, IL-6, and TNFα level in mice liver or serum, n = 6. Compared with HFD or NCD group, ∗ P < .05; ∗∗ P < .01; ∗∗∗ P < .001; ns, no significance.

Article Snippet: After blocking with 5% skim milk for 1 hour to eliminate nonspecific binding, the membrane was incubated overnight at 4°C with primary antibodies: β-actin (ABclonal, AC026, Rabbit), V5-Tag (ABclonal, AE101, Rabbit), TSG101 (Bioworld, BS91381, Rabbit), Calnexin (Bioworld, BS1438, Rabbit), CD9 (Proteintech, 60232-1-Ig, Mouse), CD63 (Abcam, ab271286, Rabbit), Ang-2 (Abcam, ab155106, Rabbit), CD31 (Proteintech, 11265-1-AP, Rabbit), OGT (Proteintech, 11576-2-AP, Rabbit), O-GlcNac (CST, #9875, Mouse), and HNF1α (Proteintech, 22426-1-AP, Rabbit).

Techniques: Western Blot, Expressing, Injection, In Vivo Imaging, Labeling, Immunohistochemistry, Enzyme-linked Immunosorbent Assay, Staining, Quantitative RT-PCR

OGT level in serum and serum sEV is positively associated with MASLD. ( A ) ELISA analysis of serum OGT expression in healthy individuals and patients with MASLD, n = 50; ( B ) ROC curve of serum OGT, AUC = .6832, P = .0016, Compared with Healthy group, ∗∗ P < .01; ( C ) Correlation analysis of serum OGT and ALT, r = .2154, P = .0438; ( D ) Correlation analysis of serum OGT and AST, r = .2493, P = .0171; ( E ) Correlation analysis of serum OGT and TG, r = .2541, P = .0197; ( F ) Immunohistochemical images of OGT expression in liver of healthy individuals and patients with MASLD; ( G ) Schematic diagram of the collection of Healthy-sEV and MASLD-sEV; ( H–I ) NTA and TEM detection of Healthy-sEV and MASLD-sEV, scale bar = 100 nm; ( J ) Western blot analysis of CD9, CD63, Alix and TSG101 protein expression in Healthy-sEV and MASLD-sEV; ( K ) Western blot analysis of OGT protein expression in Healthy-sEV and MASLD-sEV, n = 3; ( L ) ELISA analysis of of OGT in Healthy-sEV and MASLD-sEV, n = 50, Compared with Healthy-sEV group, ∗∗ P < .01; ( M ) ROC curve of OGT in serum sEV, AUC = .7228, P = .0001; ( N ) Correlation analysis of sEV-OGT and serum ALT, r = .2395, P = .0246; ( O ) Correlation analysis of sEV-OGT and serum AST, r = .2493, P = .0171; ( P ) Correlation analysis of sEV-OGT and Fib-4 score (Fib-4 = age × AST/PLT × √ALT), r = .3100, P = .0113.

Journal: Cellular and Molecular Gastroenterology and Hepatology

Article Title: OGT-enriched Hepatocyte-derived Extracellular Vesicles Promote Capillarization of Liver Sinusoidal Endothelial Cells in Metabolic Dysfunction-associated Steatotic Liver Disease

doi: 10.1016/j.jcmgh.2025.101721

Figure Lengend Snippet: OGT level in serum and serum sEV is positively associated with MASLD. ( A ) ELISA analysis of serum OGT expression in healthy individuals and patients with MASLD, n = 50; ( B ) ROC curve of serum OGT, AUC = .6832, P = .0016, Compared with Healthy group, ∗∗ P < .01; ( C ) Correlation analysis of serum OGT and ALT, r = .2154, P = .0438; ( D ) Correlation analysis of serum OGT and AST, r = .2493, P = .0171; ( E ) Correlation analysis of serum OGT and TG, r = .2541, P = .0197; ( F ) Immunohistochemical images of OGT expression in liver of healthy individuals and patients with MASLD; ( G ) Schematic diagram of the collection of Healthy-sEV and MASLD-sEV; ( H–I ) NTA and TEM detection of Healthy-sEV and MASLD-sEV, scale bar = 100 nm; ( J ) Western blot analysis of CD9, CD63, Alix and TSG101 protein expression in Healthy-sEV and MASLD-sEV; ( K ) Western blot analysis of OGT protein expression in Healthy-sEV and MASLD-sEV, n = 3; ( L ) ELISA analysis of of OGT in Healthy-sEV and MASLD-sEV, n = 50, Compared with Healthy-sEV group, ∗∗ P < .01; ( M ) ROC curve of OGT in serum sEV, AUC = .7228, P = .0001; ( N ) Correlation analysis of sEV-OGT and serum ALT, r = .2395, P = .0246; ( O ) Correlation analysis of sEV-OGT and serum AST, r = .2493, P = .0171; ( P ) Correlation analysis of sEV-OGT and Fib-4 score (Fib-4 = age × AST/PLT × √ALT), r = .3100, P = .0113.

Article Snippet: After blocking with 5% skim milk for 1 hour to eliminate nonspecific binding, the membrane was incubated overnight at 4°C with primary antibodies: β-actin (ABclonal, AC026, Rabbit), V5-Tag (ABclonal, AE101, Rabbit), TSG101 (Bioworld, BS91381, Rabbit), Calnexin (Bioworld, BS1438, Rabbit), CD9 (Proteintech, 60232-1-Ig, Mouse), CD63 (Abcam, ab271286, Rabbit), Ang-2 (Abcam, ab155106, Rabbit), CD31 (Proteintech, 11265-1-AP, Rabbit), OGT (Proteintech, 11576-2-AP, Rabbit), O-GlcNac (CST, #9875, Mouse), and HNF1α (Proteintech, 22426-1-AP, Rabbit).

Techniques: Enzyme-linked Immunosorbent Assay, Expressing, Immunohistochemical staining, Western Blot

Effects of estrogen treatment on S100A8 expression in endometrium and epithelium morphology. ( a ) S100A8 immunohistochemical staining before and after estrogen treatment (1d/7d); black arrows indicate S100A8-positive immune cells (S100A8-PICs).The blue arrow indicates the release of S100A8 from S100A8-PICs. Scale bar is 100 or 400 μm. ( b ) Rat endometrial hematoxylin–eosin staining before and after estrogen treatment (1d/7d); red arrows show disrupted cell junctions. Scale bar is 100 μm. ( c ) S100A8-PICs number in the endometrium (1/mm 2 ) before and 1 d/7d after estrogen treatment (n = 18, from six rats, the number was counted from three immunohistochemical images of each sample , mean ± SEM). ( d ) S100A8 expression in the epithelium before and 1 d/7d after estrogen treatment (n = 18, from six rats, the expression level was measured from three immunohistochemical images of each sample, mean ± SEM). * Results with P values < 0.05 were considered significant. ** Results with P values < 0.01 were considered very significant.

Journal: Scientific Reports

Article Title: S100A8 regulated by estrogen improves injured endometrial epithelium reconstruction by promoting tight junction formation and stromal cell transformation

doi: 10.1038/s41598-025-08530-0

Figure Lengend Snippet: Effects of estrogen treatment on S100A8 expression in endometrium and epithelium morphology. ( a ) S100A8 immunohistochemical staining before and after estrogen treatment (1d/7d); black arrows indicate S100A8-positive immune cells (S100A8-PICs).The blue arrow indicates the release of S100A8 from S100A8-PICs. Scale bar is 100 or 400 μm. ( b ) Rat endometrial hematoxylin–eosin staining before and after estrogen treatment (1d/7d); red arrows show disrupted cell junctions. Scale bar is 100 μm. ( c ) S100A8-PICs number in the endometrium (1/mm 2 ) before and 1 d/7d after estrogen treatment (n = 18, from six rats, the number was counted from three immunohistochemical images of each sample , mean ± SEM). ( d ) S100A8 expression in the epithelium before and 1 d/7d after estrogen treatment (n = 18, from six rats, the expression level was measured from three immunohistochemical images of each sample, mean ± SEM). * Results with P values < 0.05 were considered significant. ** Results with P values < 0.01 were considered very significant.

Article Snippet: The cultured cells were randomly divided into three groups according to the experimental design: the control, S100A8 (0.5 μg/mL, HY- P71275 ; MCE, Shanghai, China), and S100A8 + FPS-ZM 1 (5 μM, HY-19370; MCE, Shanghai, China) groups.

Techniques: Expressing, Immunohistochemical staining, Staining

Effects of uterine cavity administration of S100A8 on the distribution of S100A8-PICs and endometrial morphology. ( a ) Distribution of S100A8-positive cells in the endometrium of four different groups with estrogen treatment (control, injury, P407, and S100A8 + P407 groups). Black arrows show S100A8-PICs. S100A8-PICs were distributed around the glands and blood vessels in the control group. S100A8-PICs in the site of injury or adhesion in the injury group and in the P407 group. S100A8-PICs reverse migrated to the glands or blood vessels in the S100A8 + P407 group. Scale bar is 100 μm or 1 mm. ( b ) Endometrial thickness in the four groups (n = 15, from 5 rats; 3 position was measured randomly in an image of each rat, mean ± SEM). ( c ) The number of endometrial glands in each group (n = 10, from 10 rats, glands were counted from a uterine horn cross-section image at 40 × of each rat, mean ± SEM). ( d ) The interior wall integrity of uterine cavity in each group (n = 10, from 10 rats, data was measured from a uterine horn cross-section image at 40 × of each rat, mean ± SEM). ( e ) The number of endometrial crypts in each group (n = 10, from 10 rats, crypts were counted from a uterine horn cross-section image at 40 × of each rat, mean ± SEM). * Results with P values < 0.05 were considered significant. ** Results with P values < 0.01 were considered very significant.

Journal: Scientific Reports

Article Title: S100A8 regulated by estrogen improves injured endometrial epithelium reconstruction by promoting tight junction formation and stromal cell transformation

doi: 10.1038/s41598-025-08530-0

Figure Lengend Snippet: Effects of uterine cavity administration of S100A8 on the distribution of S100A8-PICs and endometrial morphology. ( a ) Distribution of S100A8-positive cells in the endometrium of four different groups with estrogen treatment (control, injury, P407, and S100A8 + P407 groups). Black arrows show S100A8-PICs. S100A8-PICs were distributed around the glands and blood vessels in the control group. S100A8-PICs in the site of injury or adhesion in the injury group and in the P407 group. S100A8-PICs reverse migrated to the glands or blood vessels in the S100A8 + P407 group. Scale bar is 100 μm or 1 mm. ( b ) Endometrial thickness in the four groups (n = 15, from 5 rats; 3 position was measured randomly in an image of each rat, mean ± SEM). ( c ) The number of endometrial glands in each group (n = 10, from 10 rats, glands were counted from a uterine horn cross-section image at 40 × of each rat, mean ± SEM). ( d ) The interior wall integrity of uterine cavity in each group (n = 10, from 10 rats, data was measured from a uterine horn cross-section image at 40 × of each rat, mean ± SEM). ( e ) The number of endometrial crypts in each group (n = 10, from 10 rats, crypts were counted from a uterine horn cross-section image at 40 × of each rat, mean ± SEM). * Results with P values < 0.05 were considered significant. ** Results with P values < 0.01 were considered very significant.

Article Snippet: The cultured cells were randomly divided into three groups according to the experimental design: the control, S100A8 (0.5 μg/mL, HY- P71275 ; MCE, Shanghai, China), and S100A8 + FPS-ZM 1 (5 μM, HY-19370; MCE, Shanghai, China) groups.

Techniques: Control

Effects of S100A8 on the distribution of Ki-67-positive proliferating cells in the uteri and the proliferation of endometrial cells. ( a ) Ki-67-positive proliferating cells were distributed in the endometrium or uterine interior wall in all groups (control, injury, P407, and S100A8 + P407 groups). Scale bar is 100 or 400 μm. ( b ) Number of Ki-67-positive cells in the endometrium of each group (n = 20, from ten rats, the number was counted from two immunohistochemical images of each sample, mean ± SEM). ( c ) Number of Ki-67-positive cells in the uterine interior wall of each group (n = 20, from ten rats, the number was counted from two immunohistochemical images of each sample, mean ± SEM). ( d ) Effects of S100A8 and its receptor inhibitor (FPS-ZM1) on the proliferation of cultured endometrial cells in vitro (n = 5, mean ± SEM). Scale bar is 100 μm. * Results with P values < 0.05 were considered significant. ** Results with P values < 0.01 were considered very significant.

Journal: Scientific Reports

Article Title: S100A8 regulated by estrogen improves injured endometrial epithelium reconstruction by promoting tight junction formation and stromal cell transformation

doi: 10.1038/s41598-025-08530-0

Figure Lengend Snippet: Effects of S100A8 on the distribution of Ki-67-positive proliferating cells in the uteri and the proliferation of endometrial cells. ( a ) Ki-67-positive proliferating cells were distributed in the endometrium or uterine interior wall in all groups (control, injury, P407, and S100A8 + P407 groups). Scale bar is 100 or 400 μm. ( b ) Number of Ki-67-positive cells in the endometrium of each group (n = 20, from ten rats, the number was counted from two immunohistochemical images of each sample, mean ± SEM). ( c ) Number of Ki-67-positive cells in the uterine interior wall of each group (n = 20, from ten rats, the number was counted from two immunohistochemical images of each sample, mean ± SEM). ( d ) Effects of S100A8 and its receptor inhibitor (FPS-ZM1) on the proliferation of cultured endometrial cells in vitro (n = 5, mean ± SEM). Scale bar is 100 μm. * Results with P values < 0.05 were considered significant. ** Results with P values < 0.01 were considered very significant.

Article Snippet: The cultured cells were randomly divided into three groups according to the experimental design: the control, S100A8 (0.5 μg/mL, HY- P71275 ; MCE, Shanghai, China), and S100A8 + FPS-ZM 1 (5 μM, HY-19370; MCE, Shanghai, China) groups.

Techniques: Control, Immunohistochemical staining, Cell Culture, In Vitro

Effects of S100A8 on tight junctions of endometrial epithelium or endometrial cells. ( a ) Immunohistochemical staining showing Claudin-1 distribution in the endometrium of different groups (control, injury, P407, and P407 + S100A8 groups); black arrows show Claudin-1 accumulated below the cell membrane of the lateral contact zone between adjacent cells and red arrows show cells expressing Claudin-1 in the stroma. Scale bar is 100 μm. ( b ) Claudin-1 expression in the endometrium of different groups (n = 10, mean ± SEM). ( c ) Western blot showing ZO-1 expression in endometrial cells of three different groups (control, S100A8, and S100A8 + FPS-ZM1 groups, n = 3, mean ± SEM). Actin was used as the loading control. The full-length bands can be found in supplementary Fig. 1. The bands of ZO-1 and actin cropped from different parts of the same gel. ( d ) Immunofluorescence showing the co-expression of Claudin-1 (red) and ZO-1 (green) in the endometrial cells of the three groups (n = 5, mean ± SEM). The nucleus is stained blue. The scale bar is 200 μm. * Results with P values < 0.05 were considered significant. ** Results with P values < 0.01 were considered very significant.

Journal: Scientific Reports

Article Title: S100A8 regulated by estrogen improves injured endometrial epithelium reconstruction by promoting tight junction formation and stromal cell transformation

doi: 10.1038/s41598-025-08530-0

Figure Lengend Snippet: Effects of S100A8 on tight junctions of endometrial epithelium or endometrial cells. ( a ) Immunohistochemical staining showing Claudin-1 distribution in the endometrium of different groups (control, injury, P407, and P407 + S100A8 groups); black arrows show Claudin-1 accumulated below the cell membrane of the lateral contact zone between adjacent cells and red arrows show cells expressing Claudin-1 in the stroma. Scale bar is 100 μm. ( b ) Claudin-1 expression in the endometrium of different groups (n = 10, mean ± SEM). ( c ) Western blot showing ZO-1 expression in endometrial cells of three different groups (control, S100A8, and S100A8 + FPS-ZM1 groups, n = 3, mean ± SEM). Actin was used as the loading control. The full-length bands can be found in supplementary Fig. 1. The bands of ZO-1 and actin cropped from different parts of the same gel. ( d ) Immunofluorescence showing the co-expression of Claudin-1 (red) and ZO-1 (green) in the endometrial cells of the three groups (n = 5, mean ± SEM). The nucleus is stained blue. The scale bar is 200 μm. * Results with P values < 0.05 were considered significant. ** Results with P values < 0.01 were considered very significant.

Article Snippet: The cultured cells were randomly divided into three groups according to the experimental design: the control, S100A8 (0.5 μg/mL, HY- P71275 ; MCE, Shanghai, China), and S100A8 + FPS-ZM 1 (5 μM, HY-19370; MCE, Shanghai, China) groups.

Techniques: Immunohistochemical staining, Staining, Control, Membrane, Expressing, Western Blot, Immunofluorescence

Effects of S100A8 on endometrial “double-featured” cells. ( a ) Vimentin (red) and ZO-1 (green) immunofluorescent double staining of cultured endometrial cells. Scale bar is 200 μm. ( b ) Western blot showing CK-18 and vimentin expression in endometrial cells from each group (control, S100A8, and FPS-ZM1 groups; n = 3, mean ± SEM). The full-length bands can be found in supplementary Fig. 1. Actin was used as the loading control. As the target proteins have a similar molecular weight to that of the loading control, the bands of CK18/vimentin and actin were cropped from different gels. ( c ) Immunofluorescence showing vimentin expression in endometrial cells of each group (n = 5, mean ± SEM). Scale bar is 200 μm. * Results with P values < 0.05 were considered significant. ** Results with P values < 0.01 were considered very significant.

Journal: Scientific Reports

Article Title: S100A8 regulated by estrogen improves injured endometrial epithelium reconstruction by promoting tight junction formation and stromal cell transformation

doi: 10.1038/s41598-025-08530-0

Figure Lengend Snippet: Effects of S100A8 on endometrial “double-featured” cells. ( a ) Vimentin (red) and ZO-1 (green) immunofluorescent double staining of cultured endometrial cells. Scale bar is 200 μm. ( b ) Western blot showing CK-18 and vimentin expression in endometrial cells from each group (control, S100A8, and FPS-ZM1 groups; n = 3, mean ± SEM). The full-length bands can be found in supplementary Fig. 1. Actin was used as the loading control. As the target proteins have a similar molecular weight to that of the loading control, the bands of CK18/vimentin and actin were cropped from different gels. ( c ) Immunofluorescence showing vimentin expression in endometrial cells of each group (n = 5, mean ± SEM). Scale bar is 200 μm. * Results with P values < 0.05 were considered significant. ** Results with P values < 0.01 were considered very significant.

Article Snippet: The cultured cells were randomly divided into three groups according to the experimental design: the control, S100A8 (0.5 μg/mL, HY- P71275 ; MCE, Shanghai, China), and S100A8 + FPS-ZM 1 (5 μM, HY-19370; MCE, Shanghai, China) groups.

Techniques: Double Staining, Cell Culture, Western Blot, Expressing, Control, Molecular Weight, Immunofluorescence